A B S T R A C T The in vitro cytotoxic function and target cell specificity of peripheral blood lymphocytes from selected patients with primary biliary cirrhosis and hepatitis B surface antigen-negative chronic hepatitis were investigated using 5'Cr-labeled human Chang and EL-4 mouse sarcoma cell targets in assays of spontaneous cell-mediated cytotoxicity (SCMC) and mitogen-induced cellular cytotoxicity (MICC). In addition, antibody-dependent cellular cytotoxicity (ADCC) against Chang cells was assessed. At an effector-totarget cell ratio of 100:1, the mean SCMC against Chang cells was much less in patients with primary biliary cirrhosis than that in either the controls (P < 0.001) or the patients with chronic hepatitis (P < 0.005) whereas the value for patients with chronic hepatitis did not differ significantly from that ofthe controls. The mean SCMC against EL-4 mouse sarcoma cells was also less in patients with primary biliary cirrhosis than in the controls (P < 0.005) whereas the value for chronic hepatitis was not significantly different from that of the controls or patients with primary biliary cirrhosis. In contrast, MICC against both targets and ADCC against Chang cells were similar for each group. Comparison of SCMC and MICC against both target cells, measured simultaneously, showed similar cytotoxic potential against both target cells for each group. Effector cells capable of mediating cytotoxicity in each assay were defined by testing the cytotoxic function of lymphocyte subpopulations isolated from
INTRODUCTION
In both primary biliary cirrhosis and chronic hepatitis it is possible that lymphoid cells become sensitized to hepatobiliary antigens or antigens cross-reacting with hepatobiliary antigens and are consequently cytotoxic for hepatic tissue (1, 2) . This concept is supported by the demonstration that peripheral blood lymphocytes from patients with both of these diseases produce lymphokines when exposed to antigens contained in human liver homogenates (1, 3) or to a hepatospecific lipoprotein (4, 5) . In addition, direct lymphocyte cytotoxicity against isolated xenogeneic hepatocytes has been reported to be increased in a majority of patients with chronic hepatitis and a minority of patients with primary biliary cirrhosis, compared to normal controls (6, 7) . A variable degree of increased spontaneous cell-mediated cytolysis of allogeneic tarThe Journal of Clinical Investigation Volume 60 November 1977 a1116-1128 1116 get cells has also been reported in patients with chronic hepatitis (8) (9) (10) (11) and primary biliary cirrhosis (10, 11) . However, the hepatospecificity of the observed in vitro cytotoxicity and the nature of the effector cells mediating target cytotoxicity remain poorly defined.
To evaluate further cytotoxic function in primary biliary cirrhosis and chronic hepatitis, we have investigated the cytotoxic potential of peripheral blood lymphocytes in carefully selected patients with primary biliary cirrhosis and hepatitis B surface antigen (HBsAg)'-negative chronic hepatitis using three distinct in vitro assays of cytotoxicity. These assays measured: (a) spontaneous cell-mediated cytotoxicity (SCMC); (b) mitogen-induced cellular cytotoxicity (MICC); (c) antibody-dependent cellular cytotoxicity (ADCC). Specificity of the cytotoxicity was evaluated by concurrently using as target cells an allogeneic, hepaticderived cell line (Chang liver) and a xenogeneic, nonhepatic control cell (EL-4 mouse sarcoma). In addition, studies were performed to identify the lymphocyte subpopulations capable of mediating each type of cytotoxicity in both diseases.
The results obtained show that primary biliary cirrhosis is associated with markedly diminished SCMC against Chang cells compared to either normal controls or HBsAg-negative chronic hepatitis, whereas MICC and ADCC in both patient groups are normal. The diminished spontaneous cytotoxic potential in primary biliary cirrhosis appears to be due to a selective defect in the functional capacity of a lymphocyte subpopulation which bears Fc receptors but not surface immunoglobulins (slg) and which was shown to mediate this cytotoxicity. We conclude that primary biliary cirrhosis is associated with a disorder of cytotoxic function of the peripheral blood lymphocytes and in this respect differs from HB,Ag-negative chronic hepatitis.
METHODS

Individuals studied
All patients were referred to the Section on Diseases of the Liver, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health. 10 patients with primary biliary cirrhosis and nine with chronic hepatitis were selected for study using strict criteria which included: (a) ' Abbreviations used in this paper: ADCC, antibodydependent cellular cytotoxicity; anti-HB,, antibody to hepatitis B core antigen; anti-HBs, antibody to hepatitis B surface antigen; Con A, concanavalin A; E:T, effector to target cell ratio; FCS, fetal calf serum; HB,Ag, hepatitis B surface antigen; HBV, hepatitis B virus; MICC, mitogen-induced cellular cytotoxicity; PBS, phosphate-buffered saline pH 7.2; PHA, phytohemagglutinin-W; PWM, pokeweek mitogen; SCMC, spontaneous cell-mediated cytotoxicity; slg, surface immunoglobulin; SRBC, sheep erythrocytes.
Clinical features, serum biochemical and serologic tests, and hepatic histology consistent with the respective diagnosis; Patient characteristics are summarized in Table I . The primary biliary cirrhosis group included individuals with all histologic stages of this disease as described by Scheuer (13) . The chronic hepatitis group included seven with chronic active hepatitis and two with chronic persistent hepatitis as currently defined by Boyer (14) . Liver biopsies in each of the patients with chronic active hepatitis showed striking piecemeal necrosis of hepatocytes. One patient with chronic active hepatitis and one with primary biliary cirrhosis were receiving corticosteroid therapy for their hepatic disease while an additional patient with chronic active hepatitis (no. 12) was receiving prednisone 5 mg/day as physiologic replacement for the adrenal suppression that had resulted from previous use of pharmacologic doses of corticosteroid. None of the remaining 16 patients were receiving any form of immunosuppressive therapy. Each patient receiving corticosteroid was studied before a dose was given to minimize the acute effects of corticosteroid on circulating lymphocytes (15) .
11 healthy normal volunteers of both sexes served as controls. None had a history of illness suggestive of acute hepatitis and none were receiving any medication.
Serologic tests for hepatitis B virus (HBV) infection
A negative test for HB,Ag in the serum was required for selection of patients with both primary biliary cirrhosis and chronic hepatitis. HB,Ag was assessed by radioimmunoassay (Ausria II, Abbott Laboratories, Chemical Div., North Chicago, Ill.). In addition, sera were coded and simultaneously tested for antibody to hepatitis B surface antigen (anti-HBS) by radioimmunoassay (Ausab, Abbott Laboratories) and for antibody to hepatitis B core antigen (anti-HB,) using both complement fixation and counter immunoelectrophoresis techniques by Dr. Robert J. Gerety, Bureau of Biologics, Bethesda, Md., who had no knowledge of the diagnoses. Results shown in Table I indicate past HBV infection or seroconversion in patients nos. 6 and 18 and convalescence from HBV infection in patient no. 15 (16) . By these criteria, no patient had evidence of HBV replication at the time of study.
Media and reagents
L-Glutamine-free RPMI (1640) medium and phosphatebuffered saline, pH 7.2, (PBS) were obtained from the Media Section, NIH. Eagle's minimum essential medium, nonessential amino acids, sodium pyruvate, gentamicin, and fetal calf serum (FCS) were purchased from Microbiological Associates, Bethesda, Md. FCS was incubated at 56°C for 30 min to inactivate complement before use. Penicillin-streptomycin solution, trypsin 0.25%, L-glutamine, and RPMI (1640) containing 25 mM Hepes buffer were acquired from Grand Island Biological Co., Grand Island, N.Y. Chang cell spinner culture medium was prepared from Eagle's minimum essential medium and contained 0.1 mM nonessential amino acids, 100 U/ml of penicillin, 100 ,tg/ml streptomycin, 50 ,ug/ml gentamicin, 1 mM sodium pyruvate, 4 mM L-glutamine, and 6% (vol/vol) FCS. RPMI (1640) medium was supplemented before use to contain L-glutamine 4 mM, penicillin 100 U/ml, streptoIn Vitro Cell-Mediated Cytotoxicity in Hepatobiliary Disease Preparation of effector cells for cytotoxicity assays MONONUCLEAR CELL SEPARATION Mononuclear cells from fresh, heparinized venous blood were prepared using aseptic technique by diluting the specimen 1:1 with PBS and centrifuging 8-10 ml of the mixture over 3 ml of Ficoll-Hypaque (Litton Bionetics, Div. of Litton Industries Inc., Kensington, Md.) (17) at 400 g for 40 min. Cells at the interface were collected using a Pasteur pipette and washed three times in RPMI (1640) 5% FCS before quantitation using a standard hemocytometer and Turk's solution. Cells were then diluted in RPMI (1640) 5% FCS to the final concentration required for the cytotoxicity assay. Viability was -97% as assessed by trypan blue exclusion.
ISOLATION OF MONONUCLEAR CELL SUBPOPULATIONS
To identify which lymphoid cell types mediate cytotoxicity in vitro, specific effector cell subpopulations were sequentially isolated on the basis of cell surface markers and functional capacity from two representative patients with primary biliary cirrhosis (nos. 7, 10) and chronic active hepatitis (nos. 15, 16) . The cytotoxic capacity ofeach subpopulation from these four patients was assessed in assays of SCMC, MICC, and ADCC. The assays for enumeration of cells bearing slg, Fc receptors of forming rosettes with sheep erythrocytes (SRBC) and the methods of isolation of lymphocyte subpopulations have been described elsewhere (18) . The following summarizes the isolation procedure.
Macrophage-depleted lymphocytes. Mononuclear cells were prepared as described except that centrifugation on Ficoll-Hypaque was performed at 2,250 g for 5 min. Cells at the interface were washed three times and resuspended in RPMI (1640) 10% FCS. Cells capable of endocytosing iron were removed from the cell suspension after incubation with Lymphocyte Separator Reagent as described (18) . The resulting mononuclear cells obtained have been shown to be morphologically homogeneous small lymphocvtes contaminated with -1% macrophages (18) .
Surface immunoglobulin-positive (slg+) and negative (sIg-) lymphocytes. Lymphocytes depleted ofmacrophages were fractionated on the basis of the presence or absence of surface immunoglobulin using Sephadex anti-Fab immunoabsorbent affinity chromatography as described previously (18) . Anti-Fab immunoabsorbent was prepared by covalently binding purified rabbit anti-human-(Fab')2 to Sephadex G-200 according to the method of Chess et al. (19) . The first 15 ml of effluent was collected and used for studies of sIg-lymphocytes. This fraction contained an average of 75% and 71% of the macrophage depleted lymphocyte suspension applied to the column for the chronic active hepatitis and primary biliary cirrhosis patients, respectively. Analysis of the sIgcells obtained by this technique has shown that 80-85% form rosettes with SRBC, 10-15% bear Fc receptors, and only 1-2% are contaminating sIg+ lymphocytes (18) .
The next 75 ml of effluent were collected and discarded in order to remove all nonabsorbed cells. Lymphocytes remaining on the column were then eluted after the addition of Cohn fraction II as described previously (18 
Cytotoxicity assays
Cytotoxicity assays in tissue culture tubes were performed in duplicate using a modification (21) of the method of Holm and Perlmann (22) . 1-ml aliquots of effector cell suspension containing 1 x 106 cells were first added to plastic tissue culture tubes (Falcon 3033). For assays of SCMC, 0.5 ml of RPMI (1640) 5% FCS was added to this suspension. For assays of MICC, 0.5 ml of RPMI (1640) 5% FCS containing PHA (4 ,ug/ml), Con A (20 ,ug/ml), or PWM (1:12.5 dilution) was added. Finally, 0.5 ml of 5'Cr-labeled target cells containing 1 x 104 cells were added to each tube and the contents gently mixed. Tubes were then centrifuged at 550 g for 10 min and incubated in a humidified atmosphere of 95% air and 5% CO2 for 18 h. For experiments with effector to target cell ratios other than 100:1, the ratio was altered by varying the total number of effector cells while maintaining a constant target cell number.
After incubation, the cell pellet was gently resuspended in the supemate and recentrifuged at 550 g for 10 min. A 1.0-ml aliquot of the supernate was placed in a separate tissue culture tube and both tubes were counted in a well type gamma scintillation counter (model 1085, Nuclear Chicago Corp., Div. Searle, G. D. & Co., Des Plaines, Ill.). The duration of counting for each sample was such that the standard deviation of counting for each sample was <3%. The percentage of 51Cr released from the labeled target cells was calculated using the following formula:
In Vitro Cell-Mediated Cytotoxicity in Hepatobiliary DiseasePercentage 51Cr released 2 x cpm in supernatant tube x 100. cpm in supernatant tube + cpm in pellet tube Cytotoxicity was expressed as the mean percentage of 51Cr released in duplicate assays.
Spontaneous release of 51Cr was calculated in this manner after incubating labeled target cells with medium alone. The addition of each of the three mitogens to the medium did not affect the magnitude of spontaneous 51Cr release from target cells.
Cytotoxicity assays in microtiter plates (18) were used in studies of ADCC and for determination of the cytotoxic capacity of isolated lymphocyte subpopulations in primary biliary cirrhosis and chronic active hepatitis to permit more rapid processing of large numbers of samples. Chang target cells were prepared as described and suspended at a concentration of 1 x 105 cells/ml in either RPMI (1640) 5% FCS alone or medium containing either rabbit anti-Chang antiserum or PHA at concentrations of 1:500 and 2 ig/ml, respectivel)y.
Six 0.1-mi aliquots of each of the above target cell suspensions were placed in tissue culture tubes for determination of the total 51Cr radioactivity added to microtiter plate wells. 0.1 ml of effector cells suspended in RPMI (1640) 5% FCS and 0.1 ml of target cell suspension were added to the Vbottom wells of plastic microtiter plates (Cooke Laboratory Products, Div. Dynatech Laboratories Inc., Alexandria, Va.) in triplicate. Plates were centrifuged at 55 g for 5 min and incubated in a humidified atmosphere of 95% air and 5% CO2 at 37°C for 18 h. After incubation, plates were centrifuged at 550 g for 10 min and 0.1-ml aliquots of supernate were carefully removed from each well and placed in tissue culture tubes for scintillation counting. Spontaneous release of 51Cr was determined from quadruplicate assays in which radiolabeled Chang cells had been incubated with medium alone, medium plus anti-Chang antiserum, and medium plus PHA.
Percentage release of 51Cr in microtiter cytotoxicity experiments was calculated using the following formula:
Percentage 51Cr release = 2 x supernate cpm x 100.
Total cpm/well Cytotoxicity was expressed as the mean percentage of 51Cr released in triplicate assays.
Statistical analysis
Group data were compared using Student's t test (23) .
RESULTS
Evaluation of cytotoxicity assays using unfractionated mononuclear cells Fig. 5 . In contrast to SCMC, MICC was mediated by slg-, Fc- 
DISCUSSION
Rational evaluation of immunologic function in chronic liver disease requires the study of well-defined and characterized patient populations. The observations that certain cases of chronic hepatitis are associated with hepatotoxic medications (12) or HBV infection (26) and that HBSAg-positive and negative chronic hepatitis appear to differ in clinical and immunologic features (27) (28) (29) (30) (31) (32) chronic hepatitis. These criteria provided defined patient groups which are representative of a large proportion of cases of chronic hepatitis in the U.S.A. (33, 34) and the majority of cases of primary biliary cirrhosis (35) . Further characterization of the patient groups was provided by the results of serologic tests for antiHBc and anti-HB,. These showed a similar incidence of seroconversion to HB viral antigens in both disease groups and no evidence of HBV replication (16 (18) and are, therefore, not T lymphocytes (36) . However, in the event the population of lymphocytes being studied were to contain cells sensitized to antigens on the target cell surface, the cytolysis in this assay could also be mediated by T-lymphocytes (37) .
The in vitro assay of ADCC assesses the effector cell mediated cytolysis of antibody-coated target cells. Target cell specificity is determined solely by the specificity of the anti-target cell antibody. Cytolysis occurs after interaction of the Fc receptor of a nonsensitized effector cell with the Fc portion of the antibody bound to the target cell. The effector cell in ADCC has been termed the K lymphocyte (25) . In normal humans, ADCC against Chang cells is mediated by cells within the same sIg-, Fc+ lymphocyte subpopulation which contains the effector cells for SCMC (18) . This does not necessarily indicate, however, that the effector cells for ADCC and SCMC are identical.
In the assay of MICC, the capacity of effector cells to mediate target cytolysis in the presence of plant lectins is measured. MICC has been considered an in vitro model ofthe cytotoxic potential of in vivo antigensensitized lymphocytes in which the plant lectin serves to bypass the afferent sensitization process of the effector cell (38) . The ability of mitogen to induce this form of cytotoxicity appears to be separate from its ability to induce blastogenesis (39) . MICC possibility that it may be related to innate, immunologic characteristics of individuals which might serve as a marker for susceptibility. Such a possibility has been raised by the demonstration of an association between decreased SCMC in normal humans and the HLA haplotype A3,B7 (44) . However, recent investigations of individuals with this haplotype have demonstrated decreased cytotoxic function only in males (45) . The exclusive female composition of our primary biliary cirrhosis group and the presence of the A3,B7 haplotype in only one of seven patients2 indicate that decreased SCMC in this study cannot be explained on this basis.
Although the pathogenic role of slg-, Fc+ lymphocytes in primary biliary cirrhosis and chronic hepatitis remains speculative, the results obtained in the SCMC assay are germane to the possibility that the pathogenic mechanism in both diseases involves an antigenspecific cytotoxic reaction against hepatobiliary tissue that is mediated by T lymphocytes. This follows from the fact, alluded to previously, that the SCMC assay is potentially capable of measuring cytotoxicity mediated by T lymphocytes reacting against specific target cell antigens as well as cytotoxicity mediated by SCMC effector cells (sIg-, Fc+ lymphocytes). In this study, SCMC against Chang cells did not exceed control values for primary biliary cirrhosis or chronic hepatitis patients at either an optimum E:T of 100:1 or a lower E:T (Fig. 1) . Furthermore, SCMC was not preferential for Chang cells when compared to the dissimilar EL-4 mouse sarcoma target cells. Although these results do not support an antigen-specific, T lymphocyte mediated process in either disease, the existence of such a process cannot be excluded since it remains possible that the antigens required for its demonstration are not present on the Chang cell.
Previous studies of lymphocyte cytotoxicity in primary biliary cirrhosis (6, 10, 11) and chronic hepatitis (6-11) have yielded variable results against a variety of target cells including Chang cells (8, 9) , rabbit hepatocytes (6, 7), cultured autochthanous liver tissue (10) , and fresh, autologous hepatic tissue obtained from individual patients by percutaneous liver biopsy (9, 11) . In these studies, increased cytotoxicity compared to controls was observed for at least some of the patients evaluated. However, the significance of the results in these studies is unclear because: (a) no control target cells were used to assess the target specificity of the observed results; (b) data on the nature of the effector cells which mediate SCMC have been presented only for the rabbit hepatocyte; (c) methods used to prepare autologous hepatic tissue are likely to result in a heterogeneous mixture of distinct target cell types whose relative cytolysis cannot be defined; (d) the proportion of hepatocytes contained within These features as well as differences in the target cells used, patient populations studied, and the presentation and analysis of data, make it difficult to compare these studies with one another or the present investigation. It is, however, particularly relevant to compare our results with those of Wands et al. (8, 9) . Using Chang target cells, these investigators found spontaneous cytotoxicity to be increased in four (8) and eight (9) chronic active hepatitis patients when compared to controls in an assay similar to our assay of SCMC. This finding contrasts with the findings reported here in which SCMC was found to be similar in patients with chronic hepatitis and controls. The difference between these results is not explained by Wands et al. use of Chang cells cultured in monolayers and harvested with trypsin rather than the use of untrypsinized Chang cells since our studies indicate that SCMC was not appreciably greater using trypsinized compared to untrypsinized Chang cells. Our inclusion of two patients receiving a low dose ofprednisone is also unlikely to have caused the discrepancy in results since the value for SCMC in the chronic hepatitis group is not substantially changed when the prednisone-treated patients are excluded from the analysis. However, a possible explanation for the difference in results is the composition of the patient populations studied: HBV replication was not present in any patient in the current study, whereas the majority of patients evaluated by Wands et al. were positive for HB,Ag. The presence of HBV replication may be a determining factor for the magnitude of spontaneous cytotoxicity as recent data suggests that cytotoxicity against Chang cells is increased in HB8Ag-positive compared to HB,Ag-negative chronic hepatitis patients (46) . In summary, the present investigations of the in vitro cytotoxic potential of lymphocytes from selected patients with primary biliary cirrhosis and chronic hepatitis identify the Chang cell as a useful target cell for the assessment of the cytotoxic capacity of lymphocyte subpopulations in both of these diseases. Furthermore, these studies define the presence of a dysfunction of SCMC in primary biliary cirrhosis. The difference in SCMC against Chang cells in primary biliary cirrhosis and chronic hepatitis suggests that these disease groups differ in either the circulating numbers or the cytotoxic capacity of SCMC effector cells. To the extent SCMC function relates to pathogenesis in these diseases, this difference may reflect differences in the pathogenic mechanisms of primary biliary cirrhosis and chronic hepatitis. Finally, no evidence for specific T-lymphocyte-mediated cytotoxicity against Chang cells was noted for patients with primary biliary cirrhosis or chronic hepatitis. Future attempts to evaluate the possible existence of hepatobiliary antigen-specific cytotoxicity in primary biliary cirrhosis and chronic hepatitis will require the use of target substances or cells specific to these diseases.
